Incidence of adverse events at cycle 1
| . | No. . | % . |
|---|---|---|
| Febrile neutropenia | 7 | 3.9 |
| Infection | 8 | 4.4 |
| Stomatitis (grade 3, 4) | 3 | 1.7 |
| Diarrhea (grade 3, 4) | 10 | 5.6 |
| Asthenia (severe) | 2 | 1.1 |
| Patients experiencing at least one event (TOX) | 25 | 13.9 |
| Patients experiencing febrile neutropenia, infection, or grade ≥3 diarrhea (TOX1) | 23 | 12.8 |
| . | No. . | % . |
|---|---|---|
| Febrile neutropenia | 7 | 3.9 |
| Infection | 8 | 4.4 |
| Stomatitis (grade 3, 4) | 3 | 1.7 |
| Diarrhea (grade 3, 4) | 10 | 5.6 |
| Asthenia (severe) | 2 | 1.1 |
| Patients experiencing at least one event (TOX) | 25 | 13.9 |
| Patients experiencing febrile neutropenia, infection, or grade ≥3 diarrhea (TOX1) | 23 | 12.8 |